Discovery of frequent homozygous deletions in chromosome 3p21.3 LUCA and AP20 regions in renal, lung and breast carcinomas

被引:84
作者
Senchenko, VN
Liu, J
Loginov, W
Bazov, I
Angeloni, D
Seryogin, Y
Ermilova, V
Kazubskaya, T
Garkavtseva, R
Zabarovska, VI
Kashuba, VI
Kisselev, LL
Minna, JD
Lerman, MI
Klein, G
Braga, EA
Zabarovsky, ER [1 ]
机构
[1] Karolinska Inst, Ctr Microbiol & Tumor Biol, Ctr Genom & Bioinformat, S-17177 Stockholm, Sweden
[2] Russian Acad Sci, Ctr Bioengn, Moscow 117312, Russia
[3] Russian State Genet Ctr, Moscow 117545, Russia
[4] Natl Canc Inst, Immunobiol Lab, Canc Causing Genes Sect, Ctr Canc Res, Frederick, MD 21702 USA
[5] Russian Acad Med Sci, Blokhin Canc Res Ctr, Moscow 115478, Russia
[6] Russian Acad Sci, Engelhardt Inst Mol Biol, Moscow 119991, Russia
[7] Univ Texas, SW Med Ctr, Hamon Ctr Therapeut Oncol Res, Dallas, TX 75390 USA
关键词
breast cancer; human chromosome 3p; lung cancer; renal carcinoma; tumour suppressor genes; quantitative real-time PCR;
D O I
10.1038/sj.onc.1207760
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We searched for chromosome 3p homo- and hemizygous losses in 23 lung cancer cell lines, 53 renal cell and 22 breast carcinoma biopsies using 31 microsatellite markers located in frequently deleted 3p regions. In addition, two sequence-tagged site markers (NLJ-003 and NL3-001) located in the Alu-PCR clone 20 region (AP20) and lung cancer (LUCA) regions, respectively, were used for quantitative real-time PCR (QPCR). We found frequent (10-18%) homozygous deletions (HDs) in both 3p2l.3 regions in the biopsies and lung cancer cell lines. In addition, we discovered that amplification of 3p is a very common (15-42.5%) event in these cancers and probably in other epithelial malignancies. QPCR showed that aberrations of either NLJ-003 or NL3-001 were detected in more than 90% of all studied cases. HDs were frequently detected simultaneously both in NLJ-003 or NL3-001 loci in the same tumour (P < 3-10(-7)). This observation suggests that tumour suppressor genes (TSG) in these regions could have a synergistic effect. The exceptionally high frequency of chromosome aberrations in NLJ-003 and NL3-001 loci suggests that multiple TSG(s) involved in different malignancies are located very near to these markers. Precise mapping of 15 independent HDs in the LUCA region allowed us to establish the smallest HD region in 3p21.3C located between D3S1568 (CACNA2D2 gene) and D3S4604 (SEMA3F gene). This region contains 17 genes. Mapping of 19 HDs in the AP20 region resulted in the localization of the minimal region to the interval flanked by D3S1298 and D3S3623 markers. Only four genes were discovered in this interval, namely, APRG1, ITGA9, HYA22 and VILL.
引用
收藏
页码:5719 / 5728
页数:10
相关论文
共 32 条
  • [11] Ishikawa S, 1997, DNA Res, V4, P35, DOI 10.1093/dnares/4.1.35
  • [12] RBSP3 (HYA22) is a tumor suppressor gene implicated in major epithelial malignancies
    Kashuba, VI
    Li, JF
    Wang, FL
    Senchenko, VN
    Protopopov, A
    Malyukova, A
    Kutsenko, AS
    Kadyrova, E
    Zabarovska, VI
    Muravenko, OV
    Zelenin, AV
    Kisselev, LL
    Kuzmin, I
    Minna, JD
    Winberg, G
    Ernberg, I
    Braga, E
    Lerman, MI
    Klein, G
    Zabarovsky, ER
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (14) : 4906 - 4911
  • [13] Analysis of NotI linking clones isolated from human chromosome 3 specific libraries
    Kashuba, VI
    Gizatullin, RZ
    Protopopov, AI
    Li, J
    Vorobieva, NV
    Fedorova, L
    Zabarovska, VI
    Muravenko, OV
    Kost-Alimova, M
    Domninsky, DA
    Kiss, C
    Allikmets, R
    Zakharyev, VM
    Braga, EA
    Sumegi, J
    Lerman, M
    Wahlestedt, C
    Zelenin, AV
    Sheer, D
    Winberg, G
    Grafodatsky, A
    Kisselev, LL
    Klein, G
    Zabarovsky, ER
    [J]. GENE, 1999, 239 (02) : 259 - 271
  • [14] A GROUP OF NOTI JUMPING AND LINKING CLONES COVER 2.5 MB IN THE 3P21-P22 REGION SUSPECTED TO CONTAIN A TUMOR-SUPPRESSOR GENE
    KASHUBA, VI
    SZELES, A
    ALLIKMETS, R
    NILSSON, AS
    BERGERHEIM, USR
    MODI, W
    GRAFODATSKY, A
    DEAN, M
    STANBRIDGE, EJ
    WINBERG, G
    KLEIN, G
    ZABAROVSKY, ER
    [J]. CANCER GENETICS AND CYTOGENETICS, 1995, 81 (02) : 144 - 150
  • [15] Kok K, 1997, ADV CANCER RES, V71, P27, DOI 10.1016/S0065-230X(08)60096-2
  • [16] Lerman MI, 2000, CANCER RES, V60, P6116
  • [17] Loss-of-heterozygosity analysis of small-cell lung carcinomas using single-nucleotide polymorphism arrays
    Lindblad-Toh, K
    Tanenbaum, DM
    Daly, MJ
    Winchester, E
    Lui, WO
    Villapakkam, A
    Stanton, SE
    Larsson, C
    Hudson, TJ
    Johnson, BE
    Lander, ES
    Meyerson, M
    [J]. NATURE BIOTECHNOLOGY, 2000, 18 (09) : 1001 - 1005
  • [18] Loss of heterozygosity in tumor cells requires re-evaluation: the data are biased by the size-dependent differential sensitivity of allele detection
    Liu, J
    Zabarovska, VI
    Braga, E
    Alimov, A
    Klein, G
    Zabarovsky, ER
    [J]. FEBS LETTERS, 1999, 462 (1-2): : 121 - 128
  • [19] Phelps RM, 1996, J CELL BIOCHEM, P32
  • [20] Protopopov A, 2003, CANCER RES, V63, P404